HRMY
Harmony Biosciences Holdings Inc
Price:  
28.46 
USD
Volume:  
456,315.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRMY Intrinsic Value

101.80 %
Upside

What is the intrinsic value of HRMY?

As of 2025-04-21, the Intrinsic Value of Harmony Biosciences Holdings Inc (HRMY) is 57.44 USD. This HRMY valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 28.46 USD, the upside of Harmony Biosciences Holdings Inc is 101.80%.

The range of the Intrinsic Value is 41.28 - 104.79 USD

Is HRMY undervalued or overvalued?

Based on its market price of 28.46 USD and our intrinsic valuation, Harmony Biosciences Holdings Inc (HRMY) is undervalued by 101.80%.

28.46 USD
Stock Price
57.44 USD
Intrinsic Value
Intrinsic Value Details

HRMY Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 41.28 - 104.79 57.44 101.8%
DCF (Growth 10y) 46.63 - 112.62 63.59 123.4%
DCF (EBITDA 5y) 32.37 - 38.54 34.66 21.8%
DCF (EBITDA 10y) 38.61 - 48.20 42.47 49.2%
Fair Value 63.38 - 63.38 63.38 122.69%
P/E 35.39 - 65.57 50.59 77.8%
EV/EBITDA 27.52 - 35.16 30.37 6.7%
EPV 31.15 - 42.20 36.67 28.9%
DDM - Stable 24.25 - 83.90 54.07 90.0%
DDM - Multi 29.72 - 81.95 43.86 54.1%

HRMY Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 1,633.32
Beta 1.17
Outstanding shares (mil) 57.39
Enterprise Value (mil) 1,359.58
Market risk premium 4.60%
Cost of Equity 8.02%
Cost of Debt 7.00%
WACC 7.76%